相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Augustin Luna et al.
NUCLEIC ACIDS RESEARCH (2021)
Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
S. A. Misek et al.
ONCOGENE (2020)
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance
Jose L. Orgaz et al.
CANCER CELL (2020)
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma
Christophe A. Girard et al.
CANCER RESEARCH (2020)
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
Jasper Wouters et al.
NATURE CELL BIOLOGY (2020)
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy
Megan M. Tu et al.
SCIENCE ADVANCES (2019)
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
C. Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway
M. Rathore et al.
ONCOGENE (2019)
Discoidin domain receptors: A promising target in melanoma
Coralie Reger de Moura et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism
Laura Mondragon et al.
CANCER CELL (2019)
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
Florian Rambow et al.
GENES & DEVELOPMENT (2019)
DDR1 autophosphorylation is a result of aggregation into dense clusters
David S. Corcoran et al.
SCIENTIFIC REPORTS (2019)
Clustering, Spatial Distribution, and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen I
David A. Yeung et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
Jennifer Tsoi et al.
CANCER CELL (2018)
Inhibition of DDR1-BCR signalling by nilotinib asanew therapeutic strategy for metastatic colorectal cancer
Maya Jeitany et al.
EMBO MOLECULAR MEDICINE (2018)
Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies
Robin Didier et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing
Zsofia Miskolczi et al.
ONCOGENE (2018)
Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
Whitney R. Grither et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Helen L. Young et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment
Riina Kaukonen et al.
NATURE PROTOCOLS (2017)
Fibronectin-guided migration of carcinoma collectives
Sandeep Gopal et al.
NATURE COMMUNICATIONS (2017)
Discoidin Domain Receptor 1 Mediates Myosin-Dependent Collagen Contraction
Nuno M. Coelho et al.
CELL REPORTS (2017)
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
Min Hwan Kim et al.
EMBO JOURNAL (2016)
NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
G. M. De Donatis et al.
ONCOGENE (2016)
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
Michael P. Smith et al.
CANCER CELL (2016)
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib
Anne von Maessenhausen et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Amanpreet Kaur et al.
NATURE (2016)
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
Chiara Ambrogio et al.
NATURE MEDICINE (2016)
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription
Riina Kaukonen et al.
NATURE COMMUNICATIONS (2016)
The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis
Callie A. S. Corsa et al.
CELL REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway
Barun Poudel et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Eishu Hirata et al.
CANCER CELL (2015)
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape
Inna V. Fedorenko et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
Molly H. Jenkins et al.
MATRIX BIOLOGY (2015)
Cell shape and the microenvironment regulate nuclear translocation of NF-κB in breast epithelial and tumor cells
Julia E. Sero et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Laetitia Seguin et al.
TRENDS IN CELL BIOLOGY (2015)
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis
Melanie Tichet et al.
NATURE COMMUNICATIONS (2015)
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Annelien Verfaillie et al.
NATURE COMMUNICATIONS (2015)
Lymph node fibroblastic reticular cells in health and disease
Anne L. Fletcher et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Extracellular matrix assembly: a multiscale deconstruction
Janna K. Mouw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer
Jean Albrengues et al.
CELL REPORTS (2014)
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
Hyung-Gu Kim et al.
ACS CHEMICAL BIOLOGY (2013)
NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
Nagalakshmi Nadiminty et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Discoidin domain receptor tyrosine kinases: new players in cancer progression
Rajeshwari R. Valiathan et al.
CANCER AND METASTASIS REVIEWS (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Systematic classification of melanoma cells by phenotype-specific gene expression mapping
Daniel S. Widmer et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
From genes to drugs: targeted strategies for melanoma
Keith T. Flaherty et al.
NATURE REVIEWS CANCER (2012)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Elizabeth Day et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Interaction of discoidin domain receptor 1 with collagen type 1
Gunjan Agarwal et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
SPARC represses E-cadherin and induces mesenchymal transition during melanoma development
Guillaume Robert et al.
CANCER RESEARCH (2006)
Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells
TH Landowski et al.
ONCOGENE (2003)
Taking cell-matrix adhesions to the third dimension
E Cukierman et al.
SCIENCE (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
